NCT05360537View on ClinicalTrials.gov

Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

April 20, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin Degludec / Liraglutide Injectable Product

administration of Insulin Degludec/Liraglutide

DRUG

Insulin Glargine

Administration of glargine insulin

Trial Locations (1)

90127

Internal Medicine Ward, University of Palermo, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT05360537 - Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients | Biotech Hunter | Biotech Hunter